Leukemia

The Childhood Cancer Foundation in Canada recognized the unique needs of teens with cancer and created Teen Connector, a Facebook-style website.

Updates from the American Society of Hematology meeting and the San Antonio Breast Cancer Symposium.

Drug news and recent developments

Advances in stem cell transplantation leads to a changing landscape in treating blood cancers, such as lymphoma, leukemia, and multiple myeloma.

Kids with cancer, their siblings, and parents learn relaxation, meditation, and breathing techniques.

Parents can help ease the transition from school to clinic and back again.

There are several organizations and institutions that have prepared school-related documents and checklists for parents of childhood cancer patients.

Childhood cancer survivors need long-term surveillance to keep up with late-term effects, screenings, and other health-related issues.

Researchers identify what survivors need to get physically active.

Childhood cancer survivors find lifelong care at ACE program.

CURE chooses the winning essay for it 2009 Extraordinary Healer Award for Oncology Nursing.

Reorienting kids to their academic and social lives after cancer.

The risk of secondary cancers in childhood cancer survivors and what survivors can do to protect themselves.

The Leukemia and Lymphoma Society's "First Connection" program connects volunteers with newly diagnosed patients and caregivers to help them manage the many aspects of a cancer diagnosis.

Childhood cancer survivors skip needed mammograms

Childhood cancer patients make their mark in art exhibit

What I didn't know then about childhood cancer.

Flipping cancer's "off" switch.

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

New law funds pediatric cancer research.

Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect.

Childhood cancer garners sympathy from all, but drug development from few.

Adult cancers are biologically different from childhood cancer, resulting in different treatments and different success rates.

Researchers explore ways to improve drug evaluations in pediatric clinical trials.

Advocates are working together to increase awareness and research in childhood cancers.